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Introduction 
A matrix tablet is the simplest and most cost-effective 
method to develop and manufacture an extended release 
(ER)  dosage  form.  Hydrophilic  matrices  are  flexible 
technologies to obtain desired release profiles for a wide 
range of drugs, with cellulose ethers, and in particular 
hydroxyl  propylmethylcellulose  (HPMC)  being  the 
polymers of choice for their formulations.Its popularity 
can  be  attributed  to  the  polymer’s  non-toxic  nature, 
small influence of processing variables on drug release, 
ease of compression, and its capability to accommodate 
high  levels  of  drug  loading.
1  The  percolation  theory 
studies the critical points or percolation thresholds of the 
system, where one component of the system undergoes a 
geometrical  phase  transition,  starting  to  connect  the 
whole system. These percolation thresholds are critical 
concentrations where some tablet properties (percentage 
of  drug  released,  release  rate,  mechanical  properties, 
etc.) may undergo sudden changes.
2 Percolation theory 
represents a powerful concept which covers a wide range 
of  applications  in  pharmaceutical  technology.  The 
knowledge  of  the  percolation  threshold  of  the 
components  of  the  matrix  formulations  contributes  to 
improve their design. First, in order to develop robust 
formulations, i.e., to reduce  variability problems  when 
they are prepared at industrial scale, it is important to 
know  the  concentrations  corresponding  to  the 
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percolation  thresholds.  The  percolation  thresholds 
correspond to formulations showing a high variability in 
their properties as a function of the volume fraction of 
their  components.  Therefore,  in  order  to  increase  the 
robustness  of  the  formulation,  the  nearby  of  the 
percolation  thresholds  should  be  avoided.  Second,  the 
excipient percolation threshold is the border between a 
fast release of the drug (below the threshold) and a drug 
release  controlled  by  the  formation  of  a  coherent  gel 
layer  (above  the  excipient  percolation  threshold). 
Therefore the knowledge of this threshold will allow us 
to avoid the preparation of a number of unnecessary lots, 
ring the development of a pharmaceutical formulation, 
resulting in a reduction of the time to market. 
The  percolation  theory  has  been  applied  to  describe 
controlled release inert matrix systems.
3-5, 6, 7-9 
In  recent  studies
10-14  the  existence  of  critical  points 
affecting the  water uptake and the release behavior of 
hydrophilic  matrices  has  been  observed.  Nevertheless, 
these  works  have  been  performed  employing  binary 
systems,  i.e.,  tabletscomposed  solely  with  the 
hydrophilic polymer and the drug. However, typical ER 
matrix formulations consist of a drug, release retardant 
polymer and one or more excipients. Additives such as 
fillers  or  polymeric  excipients  may  be  included  to 
improve  or  optimize  the  release  performance  of  the 
formulation  system.Previous  works  have  demonstrated 
experimentally the influence of the particle size of the 
components on the percolation threshold in hydrophilic 
matrices, as well as the importance of the initial porosity 
in the formation of the gel layer.
12, 13 
The objective of the present paper is to study in multi-
component  ER  formulations,  the  existenceof  critical 
points  governing  drug  transport  inside  hydrophilic 
matrix  systems  prepared  from  HPMC.  Various  ER 
formulations  of  phenobarbital  were  prepared 
usinglactoseasafiller  and  magnesium  stearate  as  a 
lubricant. Ethyl cellulose (EC) as a polymeric excipient 
was  also  examined  in  this  study.Then  the  percolation 
theory was applied to these multi-component hydrophilic 
matrices. 
Materials and methods   
Materials 
HPMC  K4M  (Colorcon,  UK),  EC  (Colorcon,  UK), 
Phenobarbital  (Merck,  Germany),  magnesium  stearate 
(BDH  Chemicals  Ltd,  Poole,  Dorest,  UK)  and  lactose 
monohydrate (Merck, Germany) were used.  
 
Matrix preparation 
Table 1 lists the formulations used in this study. Initially, 
all materials, with the exception of magnesium stearate, 
were blended for 10 min in a Turbula mixer (type S27, 
Erweka,  Apparatebau,  Germany).  Magnesium  stearate 
was then added and blended for an additional period of 
5min. The mixtures (total weight 300mg) were directly 
compressed at the maximum compression force accepted 
by  the  formulation  (10  KN)  with  a  hydraulic  press 
(Riken Seiki Co, Japan) fitted with a 10-mm diameter 
flat punch.  
 
 
 
Table 1. The composition and concentration of materials used in matrix formulations 
batch  Phenobarbital 
 
 
HPMC  Lactose  Mg St 
 
EC 
  (mg)  (mg)  (v/v)  (mg)  (mg)  (mg)  (v/v) 
HPMC1/lactose  100  25  9.2  172  3  -  - 
HPMC2/lactose  100  50  18.1  147  3  -  - 
HPMC3/lactose  100  75  26.8  122  3  -  - 
HPMC4/lactose  100  100  35.3  97  3  -  - 
HPMC1/EC3/lactose  100  25  8.6  97  3  75  28.9 
HPMC2/EC2/lactose  100  50  17.3  97  3  50  19.5 
HPMC3/EC1/lactose  100  75  26.2  97  3  25  9.8 
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Dissolution studies 
The  dissolution  kinetics  of  the  tablets  was  monitored 
using a tablet dissolution tester (8ST, Caleva, England). 
The  USP  paddle  –type  apparatus  was  used.  Rotation 
speed was 50 rpm and dissolution medium was 900 ml 
distilled water
15, maintained at 37 C. At each sampling 
interval, 5 ml of the dissolution medium was withdrawn 
and  an  equal  volume  of  fresh  distilled  water  was 
replaced. Phenobarbital was determined at 240 nm using 
an  ultraviolet  spectrophotometer  (Shimadzu  120A, 
Japan). Experiments were performed for three tablets for 
each  formulation  and  mean  and  standard  deviation 
values were obtained. The release rates fromcontrolled 
release polymeric matrices canbe studied using the zero-
order model (Eqs. (1) and (2) proposed byHiguchi
16, Eq. 
(3) proposed by Korsmeyer et al.
17, and Eq.(4) proposed 
by  Peppas  and  Sahlin.
18  Linear  and  non-linearleast 
squares  fitting  methodswere  used  to  determine  the 
optimumvalues  for  the  parameters  present  in  each 
equation: 
Q = kt (1) 
Q = b√t (2) 
Q = k1t
n (3) 
Q = kdt
m + krt
2m (4) 
WhereQ is the amount of drug remaining at time t; kis 
the zeroorderrelease constant on Eq.(1), b is the Higuchi 
rate  constant  on  Eq.(2),  k1  is  the  Korsmeyer–Peppas 
kinetic constant; nis a diffusionalexponent that depends 
on  the  release  mechanism  andon  the  shape  of  the 
swelling device tested.
19 For thin slabs, values ofn = 0.5 
indicate Fickian release, valuesof 0.5 <n < 1.0 indicate 
an  anomalous  (non-Fickian  or 
couplediffusion/relaxation) drug release, whereas values 
of n = 1.0 indicatea case II (purely relaxation controlled) 
drug  release.  kd  is  the  diffusional  constant;  kr  is  the 
relaxational constant andmis the diffusionalexponent that 
depends  on  geometric  shape  of  the  releasingdevice 
through its aspect ratio. 
Estimation of the percolation threshold 
In  order  to  estimate  the  percolation  threshold,  the 
behavior ofthe kinetic parameters (Higuchi’s slope “b”, 
relaxational constant of Peppas–Sahlin“kr”) with respect 
to  the  volumetric  fraction  of  HPMC  attimezero,  were 
studied.
11-14  According  to  the  fundamental  equation  of 
percolation theory(Eq. (5)), if these parameters behave 
as critical properties, we canexpect that 
X ∝S(p - pc) 
q (5) 
Where X is the studied property; S is a constant; (p-pc) is 
thedistance to the percolation threshold and q is a critical 
exponent.
20 
 
Results and discussion  
Study of release profile and release kinetics 
The  dissolution  studies  for  the  HPMC/lactose  systems 
are shown in Figure 1. 
 
Figure 1. Dissolution profiles for HPMC/lactose matrices 
The drug release profiles were evaluated both visual and 
mathematically,  taking  into  account  the  kinetic 
parameters obtained from the fitting of the obtained data 
to  the  main  kinetic  models.  According  Figure  1  an 
important  change  in  the  drug  release  profiles 
betweenHPMC1/lactose  and  HPMC2/lactose  can  be 
appreciated.  The  tablets  containing  lower  than  50  mg 
HPMC allow the free dissolution of the drug when they 
are exposed to the dissolution medium due to the fact 
that  the  gel  layer  is  not  established  since  the  first 
moment and, in these conditions, this  structure cannot 
control  the  drug  release.  The  kinetic  analysis  of  the 
release  data  confirms  this  change.  Table  2  shows  the 
values  obtained  from  Higuchi’s,zero  order, 
KorsmeyerandPeppas–Sahlin  models.  As  it  can  be 
observed,  the  Korsmeyers  release  rate  (0.059  -0.344% 
min
n) and the Higuchi’s slope, b (0.037 -0.076% min
−1/2) 
increase  between  HPMC2/lactose  and  HPMC1/lactose. 
For these matrices, according to Higuchi (r
2>0.98) and 
Peppas–Sahlin  (Kr<Kd)  equations,  drug  release  is 
governed  by  the  diffusion  process.Inthe  matrices  that 
release the drug at slow rates (above 50 mg HPMC), the 
release was controlled by the fully hydrated gel layer. 
For  these  matrices,  the  erosion  of  the  hydrophilic  gel 
structure has shown an important influence on the drug 
release.  This  indicates  a  change  in  the  drug  release 
mechanism from diffusional  to a relaxation or erosion 
controlled release. 
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Table 2. Kinetic parameters of drug release from the matrix tablets 
Batch  Zero order equation  Higushi equation  Korsmeyer equation  Pepas Sahlin equation 
%(W/W) HPMC  KO (%t
1)  r
2  b( %t
-1/2)  r
2      K(%t
n)  n  r
2  Kd 
(%t
-m) 
Kr 
(%t 
-2m) 
r
2 
HPMC1/lactose  9.2  0.0064  0.94  0.0760  0.98  0.344  0.260  0.99  0.2510  -0.0145  0.99 
HPMC2/lactose  18.1  0.0013  0.98  0.0374  0.99  0.059  0.396  0.99  0.0412  0.0006  0.99 
HPMC3/lactose  26.8  0.0011  0.99  0.0301  0.95  0.002  0.877  0.99  0.0002  0.0019  0.99 
HPMC4/lactose  35.3  0.0007  0.99  0.0203  0.92  0.001  0.957  0.97  -0.0012  0.0012  0.98 
HPMC1/EC3/lactose  8.6  0.0058  0.98  0.0685  0.99  0.320  0.252  0.99  0.2350  -0.0114  0.99 
HPMC2/EC2/lactose  17.3  0.0012  0.98  0.0364  0.99  0.024  0.548  0.99  0.0266  0.0011  0.99 
HPMC3/EC1/lactose  26.2  0.0011  0.99  0.0302  0.95  0.001  1.383  0.98  -0.0075  0.0023  0.98 
 
 
This  is  indicated  by  the  better  fit  of  the  drug  release 
kinetics to the zero-order equation and increasing the n 
value of Korsmeyer–Peppasequation from 0.26 to 0.96 
with  increasing  HPMC  amount  from  25  to  100  mg. 
Furthermore,  the  values  of  the  Peppas  and  Sahlin 
constants  confirm  thischange  on  the  drug  released 
mechanism.  The  diffusional  constant,  kd  decreases 
(0.251  to  -0.001  %  min
−m)  whereas  the  relaxational 
constant,  kr  increases  from  negative  value  to  0.001  % 
min
−2m. 
Therefore, the results obtained from the kinetics analysis 
are in agreement with the release profiles, indicating a 
clear change in the release rate and mechanism between 
matrices by increasing HPMC. From the point of view of 
percolation theory, this means that above 50 mg HPMC 
K4M, the existence of a network of HPMC (able to form 
a hydrated layer from the first moment) controls the drug 
release. 
Figure  2  shows  the  release  profile  of  drug  from 
HPMC/EC/  lactose  matrices.  According  to  this  figure, 
drug release increased as the portion of HPMC replaced 
by  EC  in  these  matrices.These  results  confirmed  the 
finding  of  Ford  et  al
21  who  investigated  the  effect  of 
replacement  HPMC  by  diluents  and  reported  that 
replacement of portions of HPMC within the matrices by 
diluents  increased  the  release  rate  of  promethazine 
hydrochloride, irrespective of whether the diluents were 
water soluble or water insoluble. 
As Takka et al.
22 - HPMCK100: Eudragit S-, Lotfipour 
et al.
23 - HPMC K4M: Eudragit RSPO- and Escudero et 
al
24-HPMC:  hydroxyl  propylcellulose-methyl 
methacrylate (HCMMA)-, it is observed that the amount 
of  HPMC  played  a  dominant  role,  affecting  the  drug 
release in these mixtures. The profiles were more similar 
to  HPMC/  EC  mixtures  in  function  of  predominant 
polymer. 
 
 
Figure 2. Dissolution profiles for HPMC/EC/lactose matrices 
In  Figure  2,  two  kinds  of  behaviours  can  be  clearly 
appreciated.  The  first  one,  corresponding  to 
batchHPMC1/EC3/lactose  shows  a  fast  drug  release, 
whereas  the  second  one  (HPMC2/EC2/lactose  and 
HPMC3/EC1/lactose) shows a modified drug release. 
In  the  case  of  batch  HPMC1/EC3/lactose,  as  it  can  be 
observed in Table 2, the studied kinetic constants, i.e., 
the  kinetic  constant  b  from  Higuchi's  model,  k  from 
Korsmeyer’s  model,  and  the  diffusional  constant  kd 
showed  higher  values  compared  to  the  batches 
HPMC2/EC2/lactose  and  HPMC3/EC1/lactose.  This 
means that the drug release from this batch is governed 
by diffusion mechanisms.  
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The kinetic analysis of the release profiles from batches 
HPMC/EC/lactose  (see  Table  2)  shows  increasing  the 
values of the relaxational constant krand decreasing the 
diffusional  constant  kd  in  the  Peppas  and  Sahlin  with 
increasing HPMC concentration.Furthermore, increasing 
the  n  value  of  Korsmeyer  equation  from  0.25  to  1.3 
confirms  the  change  on  drug  release  mechanism  to 
anerosion/relaxation  controlled  release  of  the 
drug.Finally, the analysis of the release profiles obtained 
from the studied HPMC/EC/lactose and HPMC/lactose 
matrices  indicates  clearly  the  existence  of  a  critical 
behaviour in these matrices systems. 
Estimation of HPMC percolation thresholds 
The excipient percolation threshold is one of the main 
factors governing the gel layer formation and the control 
of the drug release from hydrophilic matrices. Above the 
excipient percolation threshold, a percolating cluster of 
this component exists and the gel layer is formed from 
the  first  moment,  which  is  able  to  control  the 
hydrationand  drug  release  rate.  Below  the  excipient 
percolation threshold, the excipients donot percolate the 
system and the drug release is not controlled by the gel 
layer,  resulting  in  a  faster  release  rate.In  order  to 
estimate  the  percolation  threshold,  the  evolution  ofthe 
measured kinetic parameters (“b” slope of Higuchi, “kr” 
relaxational constant of Peppas–Sahlin) as a function of 
the  volumetric  fraction  of  HPMC  at  time  zero  were 
studied 
11-14 and the results are shown in Figure 3 and 
Figure 4. As the theory of percolation predicts (Eq. (5)), 
the  kinetic  parametersstudied  show  a  non-linear 
behaviour  as  a  function  of  thevolumetric  fraction  of 
HPMC.  The  results  show  that  HPMC  percolation 
threshold for HPMC/lactose matricesis between 9.2 and 
18.1% (v/v) ofHPMC. This factindicates that above this 
range  an  infinite  cluster  of  HPMC  has  been  formed, 
which controls the release of drug from these systems. 
The  differences  between  the  critical  pointsobtained  in 
thiswork  for  multi-component  systems,  and  the 
resultsfrom  previous  works  using  binary  systems 
(polymer  and  drug),  points  out  the  possibilitythat  the 
lactose used as a soluble filler,may help to establish the 
gel  layer.  This  is  attributable  to  this  fact  that  lactose 
decreases the concentration of polymer in gel layer and 
consequently  diffusion  of  water  into  the  table  is 
facilitated.  If  this  hypothesis  is  confirmedby  further 
studies,  the  presence  oflactosewouldbe  responsible  for 
the low values obtained for HPMC percolationthreshold 
in the matrices, expressed as HPMC volume fraction. 
 
 
Figure  3.  Higuchi's  slope  vs.  percentage  of  the  HPMC 
volumetric fraction 
 
 
 
 
Figure 4. Relaxation constant of Peppas-Sahlin vs. percentage 
of the HPMC volumetric fraction 
 
Figure  3  and  Figure  4  also  show  the  evolution  of 
measured  kinetic  parameters  for  HPMC/EC/lactose 
matrices with constant total polymer content. For these 
systems,  it  could  be  observed  a  change  between  the 
batches HPMC1/EC3/lactose and HPMC2/EC2/lactose. In 
order to analyze these figures, two opposite patterns can 
be considered.
25, 26 Pattern 1: Interchangeable polymers. 
This  hypothesis  supposes  a  full  collaboration  of  both 
polymersinorder  to  create  the  gel  layer  controlling  the 
drug  release  from  the  matrices.In  this  case  the 
concentrations of the polymers HPMC and EC will be 
fully additive, i.e., the value of the Higuchi’s slope, b, 
will be the same whenever the sum of the concentrations 
of both excipients will be the same, independent of the 
individual concentration of each one of the excipients. 
For  example,  we  could  expect  the  same  release 
behaviour  for  matrices  containing  same  total  polymer 
content  (such  as  HPMC1/EC3/lactose  and  
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HPMC2/EC2/lactose). Pattern 2: Independent excipients. 
This  hypothesis  supposes  that  at  least  the  critical 
concentration of one of the excipients has to be reached 
in  order  to  obtain  the  gel  layercontrolling  the  drug 
release, independently of the concentration of the other 
excipient. 
Looking at Figure 3 and Figure 4, we can observe for 
example  the  behavior  of  batches  HPMC1/EC3/lactose 
and  HPMC2/EC2/lactose.Despite  the  total  polymer 
content is close to 37% (v/v) for both batches (see Table 
2),  their  Higuchi’s  slope  values  are  0.068  and  0.036 
respectively.  Therefore,  matrices  having  same  total 
polymer  content,  show  very  different  drug  release 
mechanism.  These  datado  not  fulfill  the  hypothesis 
depicted in Pattern 1, indicating that the excipients are 
not  interchangeable.  In  order  to  check  the  second 
hypothesis,  which  we  have 
namedbysimilarHPMCconcentrations,  the  value  of  the 
Higuchi’s slope is almost similar for HPMC/lactose and 
HPMC/EC/  lactose  matrices  with  the  same  HPMC 
concentration  (see  Table  2).Therefore,  it  could  be 
concluded  that  collaboration  does  not  exist  between 
HPMC  and  EC  and  the  HPMC  can  be  considered  as 
acting independently of EC.A possible explanation can 
be the absence of interactions between chemical groups 
(hydrophilic groups of HPMC and hydrophobic groups 
of EC) of the polymers that avoids collaboration between 
them  to  establish  the  gel  layer  controlling  the  drug 
release,  which  has  been  also  shown  by  other 
researches.
27,28 
 
Conclusions 
Applying  the  concepts  of  the  percolation  theory  to 
HPMC/lactose  and  HPMC/EC/lactose  matrices,  the 
existenceof critical points related to HPMC percolation 
thresholdhas been confirmed. The excipient percolation 
threshold  for  HPMC/lactose  matrices  can  be  located 
between 9.2 and 18.1% (v/v) of HPMC. Above 18.1% 
(w/w) HPMC, an infinite cluster of polymer would be 
formed, controlling the hydration, gel formation and the 
drug  release.  The  percolation  threshold  for 
HPMC/EC/lactose  matrices  is  similar  to  that  for 
HPMC/lactose  matrices.Thisindicatesthe  acting  HPMC 
independently of EC as a consequence of the absence of 
collaboration between HPMC and EC. The knowledge of 
this critical barrier will be useful in order to optimize the 
design  of  the  multi-component  hydrophilic  matrix 
systems. First, reducing the time to market and second, 
increasing  their  robustness  when  they  are  prepared  at 
industrial scale, avoiding the formulation in the nearby 
of the percolation threshold. 
 
Conflict of interests 
The authors report no conflicts of interest. The authors 
alone are responsible for the content and writing of the 
paper.  
Acknowledgments 
Authors  wish  to  thanks  Tabriz  Medical  Science 
University for financial support of the study. 
 
References 
1.  Bettini  R,  Colombo  P,  Massimo  G,  Catellani  PL, 
Vitali  T.  Swelling  and  drug  release  hydrogel 
matrices:  polymer  viscosity  andmatrix  porosity 
effect. Eur J Pharm Sci  1994;2:213–219. 
2.  Zallen R. Percolation: a model for all seasons, in: G. 
Deutscher,  R.  Zallen,  J.  Adler  (Eds.),  Percolation 
Structures  and  Processes.  New  York,  Adam 
Hilger/The  Israel  Physical  Society/The  Americam 
Institute of Physics, Bristol/Jerusalem/, 1983. 
3.  Caraballo  I,  Fernandez-Are´valo  M,  Holgado  MA, 
Rabasco AM.Application of percolation theory over 
the study of biopharmaceuticalcharacteristics in inert 
matrices. Eur J Drug Metab Pharm1993;18: 130. 
4.  Caraballo  I,  Fernandez-Are´valo  M,  Holgado  MA, 
Rabasco AM. Percolation theory: application to the 
study  of  the  release  behavior  from  inert  matrix 
system. Int J Pharm 1993; 96: 175–181. 
5.  Caraballo  I,  Fernandez-Are´valo  M,  MillánM, 
Rabasco AM,  Leuenberger  H.  Study  of  percolation 
thresholds in ternary tablets. Int J Pharm 1996; 139: 
177–186. 
6.  Millán M, Caraballo I, Rabasco A. The role of the 
drug/excipient  particle  size  ratio  in  the  percolation 
model for tablets. Pharm Res 1998;15: 216–220. 
7.  Melgoza LM, Rabasco AM, Sandoval H, Caraballo I. 
Estimation  of  the  percolation  thresholds  in 
dextromethorphan  hydrobromidematrices.  Eur  J 
Pharm Sci 2001;12: 453–459. 
8.  Espina A, Caraballo I. A new wet conductivimetric 
method  to  estimate  the  drug  percolation  threshold. 
Pharm Res 2004; 21: 875–881. 
9.  Hastedt JE, Wright JL. Diffusion in porous materials 
above thepercolation threshold. Pharm Res 1990; 7: 
893–901. 
10. Caraballo  I,  Leuenberger  H.  Critical  points  in 
hydrophilic  matrices.  Abstracts  of  the  European 
Congress  on  Drug  Delivery  and  Pharmaceutical 
Technology.Seville.2004; May 10–12: p. 145.    
11. Miranda  A,  Millán  M,  Caraballo  I.  Study  of  the 
critical points in the release and hydration kinetics of 
swellable matrix type controlled delivery systems. Int 
J Pharm 2006; 311: 75–81. 
12. Miranda  A,  Millán  M,  Caraballo  I.  Study  of  the 
critical  points  in  lobenzarit  disodium  hydrophilic 
matrices for controlled drug delivery.  Chem Pharm 
Bull 2006; 54: 598–602. 
13. Miranda A, Millán M, Caraballo I. Investigation of 
the  influence  of  particle  size  on  the  excipient 
percolation thresholds of HPMC hydrophilic matrix 
tablets. J Pharm Sci 2007;96: 2746–2756.  
    |    33  Advanced Pharmaceutical Bulletin, 2011, 1(1), 27-33  Copyright © 2011 by Tabriz University of Medical Sciences 
Percolation threshold 
14. Fuertes  I,  Miranda  A,  Millán  M,  Caraballo  I. 
Estimation of the percolation thresholds in acyclovir 
hydrophilic  matrix  tablets.  Eur  J  Pharm  Biopharm 
2006;64: 336–342. 
15. United  States  Pharmacopeia  and  the  National 
Formulary (USP 29/NF 24). Rockville (MD): United 
States Pharmacopeial Convention, Inc.; 2006. 
16. Higuchi  T.  Mechanism  of  sustained  action 
medication: theoretical analysisofrate of solid drugs 
dispersed  in  solid  matrices.  J  Pharm  Sci  1963;52: 
1145–1149. 
17. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas 
NA.  Mechanismsof  solute  release  from  porous 
hydrophilic polymers. Int J Pharm 1983; 15:25–35. 
18. Peppas  NA,  Sahlin  JJ.  A  simple  equation  for  the 
description  of  solute  release.  Coupling  of  diffusion 
and relaxation. Int J Pharm 1989; 57: 169–172. 
19. Ritger  PL,  Peppas  NA.  A  simple  equation  for  the 
description  of  solute  release.I.  Fickian  and  non-
Fickian  release  from  non-swellable  devices  in  the 
form ofslabs, spheres, cylinders or discs.  J Control 
Rel 1987;5: 23–36. 
20. Bonny  JD,  Leuenberger  H.  Matrix  type  controlled 
release  systems:  I.  Effect  of  percolation  on  drug 
dissolution kinetics. Pharm Acta Helv 1991;66:160-
164. 
21. Ford  JL,  Rubinstein  MH,  Mc  Caul  F  ,  Hogan  JE, 
Edgar P. importance ofdrug type , tablet shape and 
added  diluents  on  drug  release  kinetics  from 
hydroxypropylmethylcellulose  matrix  tablets.  Int  J 
Pharm 1987;40:223-234. 
22. Takka S, Rajbhandavi S, Sakr A. Effect of anionic 
polymers on therelease of propanolol hydrochloride 
from matrix tablets. Eur J Pharm Biopharm 2001;52: 
75–82. 
23. Lotfipour F, Nokhodchi A, Saeedi M, Norouzi-Sani 
S,  Sharbafi  J,  Siahi-Shadbad  MR.  The  effect  of 
hydrophilic and lipophilic polymers andfillers on the 
release  rate  of  atenolol  from  HPMC  matrices.  Il 
Farmaco 2004;59:819–825. 
24. Escudero  JJ,  Ferrero  C,  Jim´enez-Castellanos  MR. 
Compaction  properties,  drug  release  kinetics  and 
fronts  movement  studies  from  matrices  combining 
mixtures of swellable and inert polymers: Effect of 
HPMC  of  different  viscosity  grades.  Int  J  Pharm 
2008; 351: 61–73. 
25. Contrerasa  L,  Melgozab  LM,  Villalobosc  R, 
Caraballoa  I.  Study  of  the  critical  points  of 
experimental  HPMC–NaCMC  hydrophilic  matrices. 
Int J Pharm 2010; 386: 52–60. 
26. Caraballo  I,  Fernandez-Arevalo  M,  Holgado  MA, 
Millán M, Rabasco AM, LeuenbergerH. Study of the 
percolation thresholds in ternary tablets. Int J Pharm 
1996;139: 177–186. 
27. Sucker  H,  Fuchs  F,  Speiser  P. 
PharmazeutischeTechnologie.  Stuttgart:  Georg 
ThimeVerlag; 1978. pp. 296-297. 
28. Bonny  JD,  Leuenberger  H.  Matrix  type  controlled 
release  systems:  II.  Percolation  effect  in  non- 
swellable matrices. Pharm Acta Helv 1993; 68: 25-
33. 
 